JP2008524119A5 - - Google Patents

Download PDF

Info

Publication number
JP2008524119A5
JP2008524119A5 JP2007544594A JP2007544594A JP2008524119A5 JP 2008524119 A5 JP2008524119 A5 JP 2008524119A5 JP 2007544594 A JP2007544594 A JP 2007544594A JP 2007544594 A JP2007544594 A JP 2007544594A JP 2008524119 A5 JP2008524119 A5 JP 2008524119A5
Authority
JP
Japan
Prior art keywords
carboxamide
hexafluoro
methylpropyl
hydrazine
trifluoromethylethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007544594A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008524119A (ja
JP5285276B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/043931 external-priority patent/WO2006062898A2/en
Publication of JP2008524119A publication Critical patent/JP2008524119A/ja
Publication of JP2008524119A5 publication Critical patent/JP2008524119A5/ja
Application granted granted Critical
Publication of JP5285276B2 publication Critical patent/JP5285276B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007544594A 2004-12-06 2005-12-06 アレナウイルスに関連した感染をはじめとする出血熱ウイルスを処置するための、スルホニルセミカルバジド、セミカルバジドおよび尿素、その医薬組成物および方法 Expired - Fee Related JP5285276B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63299004P 2004-12-06 2004-12-06
US60/632,990 2004-12-06
PCT/US2005/043931 WO2006062898A2 (en) 2004-12-06 2005-12-06 Compounds and methods for treating hemorrhagic fever viruses

Publications (3)

Publication Number Publication Date
JP2008524119A JP2008524119A (ja) 2008-07-10
JP2008524119A5 true JP2008524119A5 (enExample) 2010-06-17
JP5285276B2 JP5285276B2 (ja) 2013-09-11

Family

ID=36578452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007544594A Expired - Fee Related JP5285276B2 (ja) 2004-12-06 2005-12-06 アレナウイルスに関連した感染をはじめとする出血熱ウイルスを処置するための、スルホニルセミカルバジド、セミカルバジドおよび尿素、その医薬組成物および方法

Country Status (6)

Country Link
US (2) US8642596B2 (enExample)
EP (1) EP1827446A4 (enExample)
JP (1) JP5285276B2 (enExample)
AU (1) AU2005314252B2 (enExample)
CA (1) CA2590962A1 (enExample)
WO (1) WO2006062898A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410149B2 (en) 2004-12-06 2013-04-02 Siga Technologies Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
US7994221B2 (en) * 2004-12-06 2011-08-09 Siga Technologies, Inc. Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
AU2005314252B2 (en) 2004-12-06 2012-09-27 Siga Technologies, Inc. Compounds and methods for treating hemorrhagic fever viruses
US8791110B2 (en) 2006-02-01 2014-07-29 Siga Technologies, Inc. Anti-arenaviral compounds
US8106058B2 (en) 2006-02-01 2012-01-31 Siga Technologies, Inc. Anti-arenaviral compounds
JP5380078B2 (ja) 2006-03-02 2014-01-08 サイガ・テクノロジーズ・インコーポレーテッド アレナウイルス感染の治療のための抗ウイルス薬剤
WO2007100888A2 (en) 2006-03-02 2007-09-07 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
US8871746B2 (en) 2006-03-02 2014-10-28 Kineta Four, LLC Antiviral drugs for treatment of arenavirus infection
US7977365B2 (en) 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
CN101034257B (zh) * 2007-04-06 2010-09-08 上海复旦天臣新技术有限公司 用于全息记录的感光薄膜及其制备方法
US8518960B2 (en) 2007-05-23 2013-08-27 Siga Technologies, Inc. Antiviral drugs for treatment or prevention of dengue infection
ES2424214T3 (es) 2007-08-27 2013-09-30 Siga Technologies, Inc. Medicamentos antivirales para el tratamiento de una infección por Arenavirus
WO2012060820A1 (en) * 2010-11-02 2012-05-10 Siga Technologies, Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
US9452992B2 (en) 2011-08-10 2016-09-27 President And Fellows Of Harvard College Small molecule inhibitors of ebola and lassa fever viruses
WO2019051396A1 (en) 2017-09-08 2019-03-14 President And Fellows Of Harvard College SMALL MOLECULE INHIBITORS OF EBOLA VIRUSES AND LASSA FEVER, AND METHODS OF USE THEREOF

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
DE3709574A1 (de) 1987-03-24 1988-10-06 Bayer Ag Substituierte triazolinone
US5625073A (en) * 1987-06-12 1997-04-29 Bayer Aktiengesellschaft Herbicidal substituted triazolinones
DE3803523A1 (de) * 1987-06-12 1988-12-22 Bayer Ag Substituierte triazolinone
US5182303A (en) * 1988-12-27 1993-01-26 E. I. Du Pont De Nemours And Company Substituted semicarbazone arthropodicides
US5194084A (en) * 1989-05-18 1993-03-16 Bayer Aktiengesellschaft Herbicidal substituted triazolones
DE3916208A1 (de) 1989-05-18 1990-11-22 Bayer Ag Substituierte triazolone
US5534486A (en) * 1991-04-04 1996-07-09 Bayer Aktiengesellschaft Herbicidal sulphonylaminocarbonyl triazolinones having substituents bonded via oxygen
DE4111394A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel
WO1995033719A1 (en) 1994-06-02 1995-12-14 Zeneca Limited Substituted pyrrolidone, thiazolidones or oxazolidones as herbicides
US5814442A (en) * 1994-06-10 1998-09-29 Georgetown University Internally controlled virion nucleic acid amplification reaction for quantitation of virion and virion nucleic acid
US6610683B2 (en) * 1996-09-12 2003-08-26 Idun Pharmaceuticals, Inc. Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
US5945446A (en) * 1997-02-10 1999-08-31 Laubc Biochemicals, Corporation Process for preparing synthetic soil-extract materials and medicaments based thereon
US6524567B2 (en) * 1997-02-10 2003-02-25 Laub Biochemicals Corp. Synthetic soil-extract materials and medicaments for hemorrhagic fever viruses based thereon
US5904857A (en) * 1997-04-17 1999-05-18 Nalco Chemical Company 4-alkyl and aryl semicarbazides as oxygen scavengers
AU1361499A (en) 1997-10-21 1999-05-10 Merck & Co., Inc. Azapeptide acids as cell adhesion inhibitors
JPH11240859A (ja) 1997-12-26 1999-09-07 Nippon Bayer Agrochem Co Ltd フルオロ置換ベンゾイルウレア類及び有害生物防除剤
CA2370030C (en) * 1999-04-09 2007-08-14 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
US7244721B2 (en) * 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
US7335779B2 (en) * 2002-03-08 2008-02-26 Quonova, Llc Modulation of pathogenicity
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
WO2004096197A2 (en) 2003-05-02 2004-11-11 Universita Degli Studi Di Cagliari 5-aza-7-deazapurine nucleosides for treating flaviviridae
US8039504B2 (en) * 2003-06-20 2011-10-18 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
AU2004249250C1 (en) 2003-06-20 2012-04-12 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US7737168B2 (en) * 2003-06-20 2010-06-15 Siga Technologies, Inc. Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US7687641B2 (en) * 2003-06-20 2010-03-30 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
DE10348023A1 (de) 2003-10-15 2005-05-19 Imtm Gmbh Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
US8410149B2 (en) * 2004-12-06 2013-04-02 Siga Technologies Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
AU2005314252B2 (en) 2004-12-06 2012-09-27 Siga Technologies, Inc. Compounds and methods for treating hemorrhagic fever viruses
US7994221B2 (en) * 2004-12-06 2011-08-09 Siga Technologies, Inc. Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
US8106058B2 (en) * 2006-02-01 2012-01-31 Siga Technologies, Inc. Anti-arenaviral compounds
WO2007100888A2 (en) 2006-03-02 2007-09-07 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
JP5380078B2 (ja) 2006-03-02 2014-01-08 サイガ・テクノロジーズ・インコーポレーテッド アレナウイルス感染の治療のための抗ウイルス薬剤
US7977365B2 (en) * 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
US8518960B2 (en) 2007-05-23 2013-08-27 Siga Technologies, Inc. Antiviral drugs for treatment or prevention of dengue infection
ES2424214T3 (es) 2007-08-27 2013-09-30 Siga Technologies, Inc. Medicamentos antivirales para el tratamiento de una infección por Arenavirus
CA2712071A1 (en) 2008-01-15 2009-10-08 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
MX338530B (es) 2008-06-03 2016-04-21 Siga Technologies Inc Inhibidores de molecula pequeña para el tratamiento o prevencion de infeccion de virus del dengue.
WO2012060820A1 (en) 2010-11-02 2012-05-10 Siga Technologies, Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

Similar Documents

Publication Publication Date Title
JP2008524119A5 (enExample)
RU2326869C2 (ru) Производные пиридазин-3(2h)-она в качестве ингибиторов фосфодиэстеразы 4 (pde4), способ их получения, фармацевтическая композиция и способ лечения
JP2005533004A5 (enExample)
RU2004130280A (ru) Замещенные индазолы, обладающие притовораковой активностью
JP2004517080A5 (enExample)
RU2001126559A (ru) Активаторы глюкокиназы
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
RU2004127925A (ru) N3-алкилированные бензимидазольные производные в качестве ингибиторов мек
RU2455288C2 (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
JP2006077019A5 (enExample)
JP2005533024A5 (enExample)
JP2005511746A5 (enExample)
JP2005527625A5 (enExample)
JP2007500226A5 (enExample)
JP2006524248A5 (enExample)
RU2004135064A (ru) Новые замещенные индолы
JP2005538955A5 (enExample)
CA2494695A1 (en) 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
RU2006123559A (ru) Биарилсульфонамиды в качестве ммр-ингибиторов
CA2526430A1 (en) Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
RU2002127781A (ru) Производные карбоновых кислот в качестве антагонистов ip
RU2004117159A (ru) Карбамид-замещенные имидазопиридины
RU2423349C2 (ru) Гетероциклические соединения в качестве антагонистов ccr2b
JP2005522438A5 (enExample)
JP2008505874A5 (enExample)